These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4921174)

  • 21. Cyclandelate in the treatment of senility: a controlled study.
    Capote B; Parikh N
    J Am Geriatr Soc; 1978 Aug; 26(8):360-2. PubMed ID: 353121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic cerebrovascular disorders: a clinical study with cyclandelate.
    Bassi S; Albizzati MG; Sbacchi M; Frattola L
    Br J Clin Pract; 1984 Oct; 38(10):344-9. PubMed ID: 6498057
    [No Abstract]   [Full Text] [Related]  

  • 23. [Electroencephalographic and audiometric controls in presenile and senile arteriosclerotic subjects treated with an extractive sulfomucopolysaccharide complex with fibrinolytic action].
    Sfondrini E; Barberi G
    Minerva Med; 1969 Dec; 60(99 Suppl):5082-6. PubMed ID: 4188593
    [No Abstract]   [Full Text] [Related]  

  • 24. Cyclandelate in the treatment of senile mental changes: a double-blind evaluation.
    Rao DB; Georgiev EL; Paul PD; Guzman AB
    J Am Geriatr Soc; 1977 Dec; 25(12):548-51. PubMed ID: 336670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Letter: Cyclandelate and improved brain function.
    Wechsler AF
    Am J Psychiatry; 1974 Jun; 131(6):723. PubMed ID: 4827806
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of atherosclerosis in the rabbit by cyclandelate.
    Middleton A; Edwards E; White DA; Middleton B
    Br J Clin Pract Suppl; 1984; 34():39-42. PubMed ID: 6430322
    [No Abstract]   [Full Text] [Related]  

  • 27. Cyclandelate in the treatment of multi-infarct dementia. Interim findings from a multicentre study in general practice.
    Blakemore CB
    Drugs; 1987; 33 Suppl 2():110-3. PubMed ID: 3622304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cydandelate for cerebrovascular disease.
    Drug Ther Bull; 1968 Nov; 6(23):92. PubMed ID: 5697287
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of cyclandelate on perception, memory and cognition in a group of geriatric subjects.
    Aderman M; Giardina WJ; Koreniowski S
    J Am Geriatr Soc; 1972 Jun; 20(6):268-71. PubMed ID: 4555668
    [No Abstract]   [Full Text] [Related]  

  • 30. Lack of effect of cyclandelate in peripheral arterial disease.
    Vyden JK; Nagasawa K; Kanazawa M; Rose HB; Seino Y; Groseth-Robertson MF; Lander EB; Elconin SB
    Angiology; 1984 Jan; 35(1):1-11. PubMed ID: 6364892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Cyclospasmol upon sensory parameters in patients recovering from cerebrovascular accidents.
    Sourander L; Blakemore CB
    Angiology; 1978 Feb; 29(2):133-8. PubMed ID: 347985
    [No Abstract]   [Full Text] [Related]  

  • 32. [Subcortical arteriosclerotic encephalopathy (Binswanger's disease)].
    Kristensen MO
    Ugeskr Laeger; 1988 Feb; 150(8):471-5. PubMed ID: 3281348
    [No Abstract]   [Full Text] [Related]  

  • 33. A clinical trial of leptazole with nicotinic acid in the management of psycho-geriatric patients.
    Gabrynowicz JW; Dumbrill M
    Med J Aust; 1968 May; 1(19):799-802. PubMed ID: 4872367
    [No Abstract]   [Full Text] [Related]  

  • 34. Specific effects of cyclandelate on memory.
    Ananth J
    Drugs; 1987; 33 Suppl 2():97-102. PubMed ID: 3622311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical efficacy of Cyclospasmol: a review of the literature.
    Blakemore CB
    Br J Clin Pract Suppl; 1984; 34():3-9. PubMed ID: 6430319
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of cyclandelate in depressed and demented patients: a controlled study in psychogeriatric patients.
    Davies G; Hamilton S; Hendrickson E; Levy R; Post F
    Age Ageing; 1977 Aug; 6(3):156-62. PubMed ID: 331919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of procaine chlorhydrate in arteriosclerotic patients and mental functions].
    Colucci D'Amato F; Rogliani G; Feis P
    Acta Neurol (Napoli); 1975; 30(5):510-4. PubMed ID: 779410
    [No Abstract]   [Full Text] [Related]  

  • 38. Vasodilators in prevention and treatment of ischemic stroke.
    Taylor JR
    J Iowa Med Soc; 1970 Apr; 60(4):258-61. PubMed ID: 5434836
    [No Abstract]   [Full Text] [Related]  

  • 39. [Phospholipids in the treatment of arteriosclerotic pathological mental deterioration (PMD)].
    Bernardi S; Fanzago A
    Minerva Med; 1966 Jul; 57(54):2461-4. PubMed ID: 5946882
    [No Abstract]   [Full Text] [Related]  

  • 40. Management of chronic mental patients.
    Miller JF
    Geriatrics; 1965 Oct; 20(10):789-96. PubMed ID: 5833654
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.